<style>
.w-richtext p,.w-richtext li,.w-richtext td{font-size:18px;line-height:1.65}
.w-richtext h2{font-size:26px;line-height:1.35}
.w-richtext h3{font-size:22px;line-height:1.35}
.w-richtext ul{list-style-type:disc;padding-left:24px;margin:12px 0}
.w-richtext ul li{margin-bottom:8px;line-height:1.65}
.w-richtext .ac-action-plan{background:linear-gradient(135deg,#fffcf4 0%,#fff8ed 100%);border-left:5px solid #9a6841;border-radius:12px;padding:28px 24px;margin:32px 0;box-shadow:0 2px 12px rgba(0,0,0,0.06)}
.article-header-section .article-container{max-width:1080px !important;margin:0 auto !important;padding:0 20px !important}
.article-header-section .article-hero-image{display:block;width:100%;max-width:660px;margin:0}
.article-header-section .article-title{display:block !important;font-family:Georgia,serif;font-size:32px;line-height:1.25;font-weight:700;color:#313743;margin:20px 0 12px 0;text-align:left;max-width:660px}
@media (max-width:767px){.article-header-section .article-title{font-size:26px}.article-header-section .article-hero-image{max-width:100%}}
.ac-article-cta{margin-top:40px;text-align:center}
.ac-article-cta .ac-cta-lead{font-family:Georgia,serif;font-size:17px;color:#555;margin:0 0 16px 0;line-height:1.5}
.ac-article-cta a.ac-nav-cta{display:inline-flex;align-items:center;gap:10px;padding:10px 14px 10px 20px;background:#313743;color:#fff;border:1.5px solid #14D4CD;border-radius:82px;font-family:Inter,sans-serif;font-size:14px;font-weight:600;letter-spacing:0.3px;text-decoration:none;transition:transform 0.15s ease,box-shadow 0.15s ease}
.ac-article-cta a.ac-nav-cta:hover{transform:translateY(-1px);box-shadow:0 6px 18px rgba(20,212,205,0.25)}
.ac-article-cta .ac-nav-cta-arrow{width:28px;height:28px;background:#14D4CD;border-radius:50%;display:inline-flex;align-items:center;justify-content:center;flex-shrink:0}
.ac-article-cta .ac-nav-cta-arrow svg{width:14px;height:14px}
</style>
<p class="publish-date" style="font-size:13px; color:#999; margin-bottom:16px;">Published: May 12, 2026 · Last updated: May 12, 2026</p>
<div class="ac-glance" style="background-color: #ffffff; padding: 20px; border: 2px solid #b0bec5; border-radius: 8px; margin: 20px 0;"><strong>This week's brief at a glance:</strong><ul style="margin: 12px 0; padding-left: 24px;"><li style="margin-bottom:6px;">The U.S. Preventive Services Task Force recommends shared decision-making about PSA screening for men 55 to 69. Routine screening over 70 is no longer recommended for men at average risk (CDC, 2024)</li><li style="margin-bottom:6px;">PSA tests can flag both prostate cancer and benign prostate enlargement. A high reading does not automatically mean cancer, and a normal reading does not rule it out (Mayo Clinic, 2024)</li><li style="margin-bottom:6px;">"Active surveillance" is now the standard of care for many low-grade prostate cancers, replacing immediate surgery or radiation that older men sometimes received unnecessarily (Cleveland Clinic, 2024)</li></ul></div>
<p>If you are a man over 55, the PSA test conversation has changed more in the last decade than almost any other screening. Twenty years ago, an elevated PSA usually triggered a biopsy and, often, immediate surgery. Today, the response is more careful. The test still has value, but the interpretation has been refined.</p>
<p>Here is what the current evidence actually says about when prostate screening helps, when it can cause unnecessary harm, and what to do if your number comes back high.</p>
<h3>What the PSA Test Measures</h3>
<p>Prostate-specific antigen is a protein made by both normal prostate cells and cancerous ones. The blood test reports how much PSA is circulating. Higher numbers can signal cancer, but they can also signal benign prostatic hyperplasia (BPH), recent ejaculation, vigorous exercise, an infection, or a recent prostate exam.</p>
<p>According to the (<a href="https://www.cdc.gov/prostate-cancer/screening/index.html" target="_blank" rel="noopener">CDC, 2024</a>), the test has real value but is also imperfect: it produces false positives and false negatives at meaningful rates, which is why the surrounding decision-making matters as much as the number itself.</p>
<h3>The Shared Decision-Making Window: Ages 55 to 69</h3>
<p>For men 55 to 69, the USPSTF recommends a conversation with your physician rather than a blanket "yes" or "no" on screening. The benefits are real (early detection can lower mortality from prostate cancer) but so are the harms (false positives, anxiety, unnecessary biopsies, treatment side effects). Mayo Clinic notes that the lifetime risk of dying from prostate cancer is much smaller than the lifetime risk of being diagnosed with it (<a href="https://www.mayoclinic.org/diseases-conditions/prostate-cancer/in-depth/prostate-cancer/art-20048087" target="_blank" rel="noopener">Mayo Clinic, 2024</a>).</p>
<p>Men at higher risk, including Black men and men with a first-degree relative who had prostate cancer, often start the conversation earlier (age 45) and weigh the screening benefit more heavily. Men with low risk and short life expectancy weigh it less.</p>
<h3>The Active Surveillance Shift</h3>
<p>Until about 15 years ago, most prostate cancer diagnoses led to immediate treatment: prostatectomy, radiation, or hormone therapy. Many men suffered urinary, sexual, and bowel side effects for cancers that would never have progressed to cause symptoms.</p>
<p>The current standard for low-grade disease is active surveillance. Cleveland Clinic estimates that 40 to 60 percent of newly diagnosed prostate cancers in men over 65 qualify for surveillance: regular PSA monitoring, periodic MRI or biopsy, and treatment only if the cancer shows signs of progression (<a href="https://my.clevelandclinic.org/health/diseases/8634-prostate-cancer" target="_blank" rel="noopener">Cleveland Clinic, 2024</a>). The trade-off is real but acceptable: small risk of progression in exchange for avoiding the side effects of treatment.</p>
<h3>Over 70 and Routine Screening</h3>
<p>For men over 70 at average risk, the USPSTF recommends against routine PSA screening. The reasoning is that prostate cancer in this age group is often slow-growing enough that other causes of death will likely come first, and the harms of detection and treatment outweigh the modest survival benefit.</p>
<p>This is not a blanket rule. A 72-year-old in excellent health with a family history may still benefit. A 78-year-old with multiple chronic conditions usually does not. The decision is individual.</p>
<p>For more on screening tests that have shifted in the same direction, see our article on <a href="/articles/colorectal-cancer-screening-now-starts-at-45-what-changed-and-why">colorectal cancer screening</a>.</p>
<div class="ac-action-plan" style="background: linear-gradient(135deg, #fffcf4 0%, #fff8ed 100%); border-left: 5px solid #9A6841; border-radius: 12px; padding: 28px 24px; margin: 32px 0; box-shadow: 0 2px 12px rgba(0,0,0,0.06);"><div style="display: flex; align-items: center; gap: 10px; margin-bottom: 20px;"><svg width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="#9A6841" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M9 5H7a2 2 0 00-2 2v12a2 2 0 002 2h10a2 2 0 002-2V7a2 2 0 00-2-2h-2"/><rect x="9" y="3" width="6" height="4" rx="1"/><path d="M9 14l2 2 4-4"/></svg><span style="font-family: Georgia, serif; font-size: 22px; font-weight: 700; color: #313743;">Your Coach's Recommendations</span></div><div style="display: flex; gap: 14px; margin-bottom: 16px; align-items: flex-start;"><div style="min-width: 36px; width: 36px; height: 36px; background: #9A6841; border-radius: 50%; display: flex; align-items: center; justify-content: center; color: #fff; font-weight: 700; font-size: 16px; flex-shrink: 0;">1</div><div><div style="font-weight: 700; color: #313743; font-size: 15px; margin-bottom: 2px;">Schedule a Screening Conversation Between Ages 55 and 69.</div><div style="color: #6b7280; font-size: 13.5px; line-height: 1.5;">Ask your physician about your individual risk, family history, and how PSA results would be interpreted. The conversation matters more than the test result.</div></div></div><div style="display: flex; gap: 14px; margin-bottom: 16px; align-items: flex-start;"><div style="min-width: 36px; width: 36px; height: 36px; background: #9A6841; border-radius: 50%; display: flex; align-items: center; justify-content: center; color: #fff; font-weight: 700; font-size: 16px; flex-shrink: 0;">2</div><div><div style="font-weight: 700; color: #313743; font-size: 15px; margin-bottom: 2px;">If You Are Black or Have Family History, Start Earlier.</div><div style="color: #6b7280; font-size: 13.5px; line-height: 1.5;">Men with elevated risk often begin the conversation at age 45. The screening decision is the same, but the threshold for action is lower.</div></div></div><div style="display: flex; gap: 14px; margin-bottom: 20px; align-items: flex-start;"><div style="min-width: 36px; width: 36px; height: 36px; background: #9A6841; border-radius: 50%; display: flex; align-items: center; justify-content: center; color: #fff; font-weight: 700; font-size: 16px; flex-shrink: 0;">3</div><div><div style="font-weight: 700; color: #313743; font-size: 15px; margin-bottom: 2px;">Ask About Active Surveillance Before Agreeing to Treatment.</div><div style="color: #6b7280; font-size: 13.5px; line-height: 1.5;">If you are diagnosed with low-grade prostate cancer, ask explicitly whether surveillance is appropriate. Many men qualify and the side-effect math favors waiting in that scenario.</div></div></div><div style="border-top: 1px solid #e5ddd4; margin: 16px 0;"></div><div style="display: flex; justify-content: center; align-items: center; gap: 10px; flex-wrap: wrap;"><button onclick="acPrintPlan()" style="background: none; border: 1px solid #d3cabe; border-radius: 8px; padding: 10px 16px; font-size: 13px; color: #6b7280; cursor: pointer; display: flex; align-items: center; gap: 6px;"><svg width="14" height="14" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><polyline points="6 9 6 2 18 2 18 9"/><path d="M6 18H4a2 2 0 01-2-2v-5a2 2 0 012-2h16a2 2 0 012 2v5a2 2 0 01-2 2h-2"/><rect x="6" y="14" width="12" height="8"/></svg>Print</button></div></div>
<div style="margin-top: 32px; padding-top: 0;">
<div style="width: 60px; height: 2px; background: linear-gradient(90deg, #9A6841, #be7b4c); border-radius: 2px; margin-bottom: 20px;"></div>
<p style="font-family: Georgia, serif; font-size: 16px; font-style: italic; color: #777; margin: 0 0 6px 0; letter-spacing: 0.3px; padding-left: 38px;">To your health,</p>
<div style="display: flex; align-items: center; gap: 4px; margin-bottom: 4px;">
<img src="https://cdn.prod.website-files.com/69be130d412f9c2c202307ef/69c539b9526b266e2cba5521_ageless-coach-logo-black.png" alt="AC" style="width: 34px; height: 34px; object-fit: contain;">
<p style="font-family: Georgia, serif; font-size: 22px; font-weight: 700; color: #313743; margin: 0; letter-spacing: 0.5px;">Ageless Coach</p>
</div>
<p style="font-family: -apple-system, BlinkMacSystemFont, Segoe UI, sans-serif; font-size: 11px; font-weight: 600; color: #be7b4c; letter-spacing: 2px; text-transform: uppercase; margin: 0 0 0 28px;">Age Strong. Live Long.</p>
</div>
<div style="margin-top: 28px; padding-top: 20px; border-top: 1px solid #e5e7eb; text-align: center;">
<p style="font-family: -apple-system, BlinkMacSystemFont, Segoe UI, sans-serif; font-size: 13px; font-weight: 700; color: #6b7280; letter-spacing: 2px; text-transform: uppercase; margin: 0 0 16px 0;">Trusted Sources Behind This Article</p>
<div style="display: flex; justify-content: center; gap: 10px; flex-wrap: wrap;">
<a href="https://www.cdc.gov/prostate-cancer/screening/index.html" target="_blank" rel="noopener" style="display: inline-block; background: #fff; border: 1.5px solid #9A6841; color: #9A6841; padding: 8px 20px; border-radius: 20px; font-size: 14px; font-weight: 600; letter-spacing: 0.3px; text-decoration: none; transition: background 0.2s ease, color 0.2s ease;">CDC</a>
<a href="https://www.mayoclinic.org/diseases-conditions/prostate-cancer/in-depth/prostate-cancer/art-20048087" target="_blank" rel="noopener" style="display: inline-block; background: #fff; border: 1.5px solid #9A6841; color: #9A6841; padding: 8px 20px; border-radius: 20px; font-size: 14px; font-weight: 600; letter-spacing: 0.3px; text-decoration: none; transition: background 0.2s ease, color 0.2s ease;">Mayo Clinic</a>
<a href="https://my.clevelandclinic.org/health/diseases/8634-prostate-cancer" target="_blank" rel="noopener" style="display: inline-block; background: #fff; border: 1.5px solid #9A6841; color: #9A6841; padding: 8px 20px; border-radius: 20px; font-size: 14px; font-weight: 600; letter-spacing: 0.3px; text-decoration: none; transition: background 0.2s ease, color 0.2s ease;">Cleveland Clinic</a>
</div>
</div>
<p style="font-size: 12px; color: #999; margin-top: 40px; line-height: 1.5;"><em>This content is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Reading this article does not create a provider-patient relationship. Always consult your physician or qualified healthcare provider before making changes to your diet, exercise, or health routine. Ageless Coach is not liable for any actions taken based on this information.</em></p>
<div class="ac-faq" style="margin-top:40px; border-top:1px solid #e5e7eb; padding-top:32px;">
<h2 style="font-family:Georgia,serif; font-size:20px; font-weight:700; color:#313743; margin:0 0 20px 0;">Frequently Asked Questions</h2>
<details style="border:1px solid #e5e7eb; border-radius:8px; margin-bottom:10px; overflow:hidden;">
<summary style="padding:14px 18px; font-weight:600; font-size:15px; color:#313743; cursor:pointer; list-style:none; display:flex; justify-content:space-between; align-items:center;">
What PSA number should I worry about?
<svg width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="#9A6841" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" aria-hidden="true"><polyline points="6 9 12 15 18 9"/></svg>
</summary>
<div style="padding:0 18px 16px; font-size:18px; color:#555; line-height:1.65;">There is no single threshold. PSA rises naturally with age, and what matters more than one number is the trend over time. A PSA that rises sharply from year to year (a "PSA velocity" change) is a stronger signal than a one-time elevated reading. Your physician will interpret in the context of your age, history, and prior values.</div>
</details>
<details style="border:1px solid #e5e7eb; border-radius:8px; margin-bottom:10px; overflow:hidden;">
<summary style="padding:14px 18px; font-weight:600; font-size:15px; color:#313743; cursor:pointer; list-style:none; display:flex; justify-content:space-between; align-items:center;">
Does a high PSA always mean cancer?
<svg width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="#9A6841" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" aria-hidden="true"><polyline points="6 9 12 15 18 9"/></svg>
</summary>
<div style="padding:0 18px 16px; font-size:18px; color:#555; line-height:1.65;">No. Benign prostatic hyperplasia (BPH), prostatitis, urinary tract infection, recent ejaculation, vigorous exercise, and even recent bike riding can elevate PSA. Roughly 70 to 75 percent of men with elevated PSA who go to biopsy do not have cancer.</div>
</details>
<details style="border:1px solid #e5e7eb; border-radius:8px; margin-bottom:10px; overflow:hidden;">
<summary style="padding:14px 18px; font-weight:600; font-size:15px; color:#313743; cursor:pointer; list-style:none; display:flex; justify-content:space-between; align-items:center;">
What is the difference between PSA and a digital rectal exam?
<svg width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="#9A6841" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" aria-hidden="true"><polyline points="6 9 12 15 18 9"/></svg>
</summary>
<div style="padding:0 18px 16px; font-size:18px; color:#555; line-height:1.65;">PSA is a blood test. DRE is a physical exam in which the provider feels the prostate through the rectum to check for asymmetry, hardness, or nodules. Together they detect more cancers than either alone, but DRE has fallen out of routine use in some practices because of its low specificity. Your doctor will recommend based on guidelines and your situation.</div>
</details>
<details style="border:1px solid #e5e7eb; border-radius:8px; margin-bottom:10px; overflow:hidden;">
<summary style="padding:14px 18px; font-weight:600; font-size:15px; color:#313743; cursor:pointer; list-style:none; display:flex; justify-content:space-between; align-items:center;">
How often should I get tested?
<svg width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="#9A6841" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" aria-hidden="true"><polyline points="6 9 12 15 18 9"/></svg>
</summary>
<div style="padding:0 18px 16px; font-size:18px; color:#555; line-height:1.65;">If you and your doctor decide on screening, every two years is reasonable for most men with normal baseline PSA. Annual testing has higher detection rates but also higher false-positive rates. Men with rising or elevated values may be tested more frequently.</div>
</details>
<details style="border:1px solid #e5e7eb; border-radius:8px; margin-bottom:10px; overflow:hidden;">
<summary style="padding:14px 18px; font-weight:600; font-size:15px; color:#313743; cursor:pointer; list-style:none; display:flex; justify-content:space-between; align-items:center;">
Can I lower my PSA naturally?
<svg width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="#9A6841" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" aria-hidden="true"><polyline points="6 9 12 15 18 9"/></svg>
</summary>
<div style="padding:0 18px 16px; font-size:18px; color:#555; line-height:1.65;">Some lifestyle factors are associated with lower PSA: regular exercise, maintaining healthy weight, and a diet rich in vegetables. Saw palmetto and other supplements show mixed evidence. Importantly, "lowering PSA" is not a goal in itself. The goal is detecting clinically meaningful disease, which lifestyle changes do not directly affect.</div>
</details>
<details style="border:1px solid #e5e7eb; border-radius:8px; margin-bottom:10px; overflow:hidden;">
<summary style="padding:14px 18px; font-weight:600; font-size:15px; color:#313743; cursor:pointer; list-style:none; display:flex; justify-content:space-between; align-items:center;">
What happens if my biopsy finds low-grade cancer?
<svg width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="#9A6841" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" aria-hidden="true"><polyline points="6 9 12 15 18 9"/></svg>
</summary>
<div style="padding:0 18px 16px; font-size:18px; color:#555; line-height:1.65;">Most low-grade cancers (Gleason 6, also called grade group 1) are candidates for active surveillance. You continue periodic monitoring with PSA and possibly MRI, and treatment is reserved for cancers that show signs of progression. This approach avoids the side effects of treatment for cancers that likely would never cause symptoms.</div>
</details>
</div>
<div class="ac-article-cta">
<p class="ac-cta-lead">Want one verified-science article like this every week?</p>
<a href="/newsletter" class="ac-nav-cta">
Get Better Health, Weekly
<span class="ac-nav-cta-arrow">
<svg viewBox="0 0 18 18" fill="none" xmlns="http://www.w3.org/2000/svg" aria-hidden="true"><path d="M4.24 13.59L12.73 5.11" stroke="#0D1B2A" stroke-width="1.8"/><path d="M4.95 4.4H13.44V12.89" stroke="#0D1B2A" stroke-width="1.8"/></svg>
</span>
</a>
</div>
Get Better Health, Weekly